Oncologianova GmbH Gesellschaft fuer Innovationen in der Onkologie

Recklinghausen 5 trials 1 recruiting

5 Registered trials

1 Currently recruiting

Organisation

Oncologianova GmbH Gesellschaft fuer Innovationen in der Onkologie

Location

Recklinghausen, Germany

Identifier

ORG-100044151

Address

Am Stadion 9, Hillerheide, 45659, Germany

Departments

Oncologianova GmbH Gesellschaft fuer Innovationen in der Onkologie
Oncology
Onkologie
Praxis

Clinical trials at this site (5)

Search interface

A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants with Early Breast Cancer (EMBER-4) Recruiting

2022-501007-28-00 Breast Neoplasms 5 2023-04-18
Sacituzumab Govitecan in primary HER2-negative breast cancer (SASCIA) Ended

2023-510390-33-00 HER2-negative breast cancer patients with high relapse 5 2020-10-23
Adjuvant Dynamic marker - Adjusted Personalized Therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate-risk… Ended

2024-515769-32-00 HR+/HER2- early breast cancer 5 2019-07-02
Olaparib as adjuvant treatment in patients with germline BRCA mutated high risk HER2negative primary breast cancer. Ended

2024-511096-15-00 Breast Cancer 5 2014-08-01
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negati… Ended

2023-508472-11-00 Patients with early breast cancer 5 2018-06-13